1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Cardiovascular Devices Market Trends
  5. > China PTCA Balloon Market Investment Report, 2014-2016

China PTCA Balloon Market Investment Report, 2014-2016

  • September 2014
  • -
  • Research In China
  • -
  • 114 pages

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. Therefore, the development of PTCA balloon industry is closely related to that of PCI.

As national economy develops and people’s living standard improves, the number of patients receiving PCI has been on the rise year by year, and totaled 454,505 cases in China in 2013, up 16.9% from a year earlier. Demand for PTCA balloon during the same period reached 1.186 million sets, rising by 13.8% on a year-on-year basis.

Despite year-on-year growth in the number of PCI cases in China, the penetration is still very low. In 2013, 309.42 per 1 million were people receiving PCI treatment in China, compared with 1800 cases in the United States, showing a vast space for development of the Chinese PCI market and a bright future for PTCA balloon industry. It is expected that China’s demand for PTCA balloon will hit 1.824 million sets by 2016.

At present, the Chinese PTCA balloon market is still dominated by foreign companies, such as Medtronic, Abbott, Boston Scientific, Goodman, Terumo, etc. However, local Chinese PTCA balloon companies are improving their competitiveness, with overall market share rising to about 40% in 2013 as opposed to 20% in 2009.

Local Chinese PTCA balloon companies include Lepu Medical, MicroPort, JW Medical, Yinyi, Neich Medical (Shenzhen), Synexmed, Sino Medical and Demax Medical, of which Lepu Medical, MicroPort, Neich Medical (Shenzhen) and Sino Medical manufacture both PTCA balloon catheter for delivering coronary stent and PTCA balloon, JW Medical manufactures only PTCA balloon for delivering coronary stent, and Demax Medical produces only PTCA balloon.

MicroPort is a bellwether in the Chinese coronary stent system market. On Jan. 20, 2014, MicroPort announced that it would acquire drug-eluting stent-related assets of Cordis under Johnson & Johnson. After the acquisition is completed, MicroPort’s share in drug-eluting stent market will rise by over 10%. This will also promote company’s business development of PTCA balloon for delivering coronary stent. MicroPort now can manufacture more than 200,000 sets of PTCA balloon annually.

Lepu Medical is a leading player in China PTCA balloon industry. The company now has PTCA balloon dilatation catheter capacity of 100,000 sets and coronary stent delivery system capacity of 170,000 sets.

China PTCA Balloon Catheter Market Investment Report, 2014-2016 focuses on the following:

Operating environment of the Chinese PTCA balloon market, including macro environment, policy climate, medical & health care level and status quo of China medical device industry;
Overview of the Chinese PTCA balloon market, covering status quo, development bottlenecks, supply & demand, competitive landscape and development outlook and forecast;
Investment in the Chinese PTCA balloon market, including favorable and unfavorable factors, economic benefit and site selection of plants;
Operation and PTCA balloon business of 5 foreign and 9 Chinese PTCA balloon companies.

Table Of Contents

China PTCA Balloon Market Investment Report, 2014-2016
1. Concepts Related to PTCA Balloon Industry
1.1 Definition and Classification of PTCA Balloon
1.2 Definition and Classification of Interventional Medical Device

2. Operating Environment of Chinese PTCA Balloon Market
2.1 Macro Environment
2.2 Policy Climate
2.3 Medical and Health Care Level
2.4 Status Quo of China Medical Device Industry

3. Overview of Chinese PTCA Balloon Market
3.1 Status Quo
3.2 Development Bottleneck
3.3 Supply and Demand
3.3.1 Supply
3.3.2 Demand
3.4 Competitive Landscape
3.5 Development Outlook and Forecast

4. Investment in Chinese PTCA Balloon Market
4.1 Favorable Factors
4.1.1 Strong Support by National Industrial Policy
4.1.2 Financial Incentives
4.1.3 Expanding Market Demand
4.1.4 Increasingly Standardized Market
4.2 Unfavorable Factors
4.2.1 Mounting Risk of Price Drop
4.2.2 Shortage of Related Production Materials and Equipment
4.2.3 Foreign Non-Tariff Barriers
4.3 Economic Benefit
4.4 Site Selection of Plants
4.4.1 Chengdu
4.4.2 Hangzhou
4.5 Construction of GMP Plant

5. Major Chinese Companies
5.1 Lepu Medical
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 PTCA Balloon Business
5.1.6 RandD and Investment
5.1.7 Forecast and Outlook
5.2 MicroPort
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 PTCA Balloon Business
5.2.5 RandD and Investment
5.2.6 Forecast and Outlook
5.3 JW Medical
5.3.1 Profile
5.3.2 PTCA Balloon Business
5.4 Dalian Yinyi
5.4.1 Profile
5.4.2 PTCA Balloon Business
5.5 Neich Medical (Shenzhen)
5.5.1 Profile
5.5.2 PTCA Balloon Business
5.6 SCW Medicath
5.6.1 Profile
5.6.2 PTCA Balloon Business
5.7 Synexmed
5.7.1 Profile
5.7.2 PTCA Balloon Business
5.8 Sino Medical
5.8.1 Profile
5.8.2 PTCA Balloon Business
5.9 Demax Medical (Beijing)
5.9.1 Profile
5.9.2 PTCA Balloon Business

6. Major Foreign Companies
6.1 Medtronic
6.1.1 Profile
6.1.2 Operation
6.1.3 PTCA Balloon Business
6.1.4 Operation in China
6.2 Boston Scientific
6.2.1 Profile
6.2.2 Operation
6.2.3 PTCA Balloon Business
6.2.4 Operation in China
6.3 Abbott
6.3.1 Profile
6.3.2 Operation
6.3.3 PTCA Balloon Business
6.3.4 Operation in China
6.4 Terumo
6.4.1 Profile
6.4.2 Operation
6.4.3 PTCA Balloon Business
6.4.4 Operation in China
6.5 B. Braun Melsungen
6.5.1 Profile
6.5.2 Operation
6.5.3 PTCA Balloon Business
6.5.4 Operation in China

Companies Mentioned

Lepu Medical
JW Medical
Dalian Yinyi
Neich Medical (Shenzhen)
SCW Medicath
Sino Medical
Demax Medical (Beijing)
Boston Scientific
B. Braun Melsungen

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
European Market Report for Central Venous Catheters 2017 - MedCore

European Market Report for Central Venous Catheters 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The European CVC market includes acute and chronic CVCs. Acute CVCs are classified as either conventional acute CVCs or antimicrobial acute CVCs. The acute CVC market includes conventional ...

European Market Report for Dialysis Catheters 2017 - MedCore

European Market Report for Dialysis Catheters 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The European market for dialysis catheters comprises the acute hemodialysis, chronic hemodialysis and peritoneal dialysis catheter segments. The chronic hemodialysis catheter market is segmented ...

Biodegradable Stents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Biodegradable Stents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • January 2017
  • by Transparency Market Research

Global Biodegradable Stents Market: Overview Biodegradable Stents are the third generation of stents used in the treatment of coronary artery diseases, which are completely absorbed in the body after the ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.